// App-Quantinova.ai

780 : Correlating LRRK2 activation status in peripheral blood to urine BMPs in monogenic and idiopathic Parkinson’s disease

Researchers

Presenter

  • S. Gomes

Principal Investigators

  • F. Tonelli

  • E. Tolosa

  • M. Marti

  • D. Anderson

  • N. Pratuseviciute

  • F. Hsieh

  • T. Bruecke

  • T. Koenig

  • C. Hotzy

  • J. Ruiz-Martnez

  • A. Bergareche-Yarza

  • E. Mondragn Rezola

  • A. Vinagre Aragn

  • I. Croitoru

  • A. Gorostidi Pagola

  • L. Paternain Markinez

  • F. Valldeoriola

  • K. Merchant

  • S. Padmanabhan

  • A. Zimprich

  • D. Alessi

  • E. Sammler

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Velaglucerase alfa

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved